There is a significant unmet clinical need within the current interventional cardiology field for a new technology and treatment that may impact the treatment of heart attack and its prevention. There has been a lack of innovation in recent years in this market, and the introduction of therapies that are alternatives to implanted devices may potentially overcome some of the limitations of today’s technologies for application to stabilisation of vulnerable plaques. In combination with non invasive imaging technologies such as CT scanning cryotherapy may finally open up the possibility of applying therapy to prevent future coronary events by locating areas of inflammation that could be treated to prevent plaque rupture leading to heart attack.
CLEAR AND PROVEN PATH TO COMMERCIALIZATION
- Avoids use of implants and well documented problems / smoother regulatory path.
- Experienced team.
- Strong IP with worldwide patent protection for use of cryoenergy for treatment of inflamed plaque.
LARGE MARKET OPPORTUNITY
- Medium term market potential in excess of €5billion for heart attack prevention working with strategic partner to enable image guidance to target therapy.